SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
3.610
+0.120 (3.44%)
At close: Oct 9, 2026, 4:00 PM EDT
3.600
-0.010 (-0.28%)
After-hours: Oct 9, 2026, 7:55 PM EDT
SeaStar Medical Holding Employees
SeaStar Medical Holding had 18 employees as of June 30, 2026. That makes SeaStar Medical Holding the 38,604th largest employer in the world and 5,579th in the United States.
Employees
18
Change
n/a
Growth
n/a
Revenue / Employee
$95,167
Profits / Employee
-$757,056
Market Cap
18.99M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 18 | - | - |
| Mar 31, 2026 | 17 | -2 | -10.53% |
| Dec 31, 2025 | 17 | -2 | -10.53% |
| Dec 31, 2024 | 19 | 7 | 58.33% |
| Dec 31, 2023 | 12 | 3 | 33.33% |
| Dec 31, 2022 | 9 | 6 | 200.00% |
| Sep 30, 2022 | 8 | 5 | 166.67% |
| Jun 30, 2022 | 3 | - | - |
| Mar 31, 2022 | 3 | - | - |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Cerenome | 28 |
| Palatin Technologies | 25 |
| Citius Pharmaceuticals | 23 |
| BioCardia | 21 |
| Lipocine | 14 |
| Actuate Therapeutics | 12 |
| Tvardi Therapeutics | 12 |
| AEON Biopharma | 8 |
ICU News
- 3 days ago - SeaStar Medical granted Breakthrough Device Designation for SCD therapy - TheFly
- 3 days ago - FDA Grants SeaStar Medical Breakthrough Device Designation for its SCD Therapy for the Treatment of Hyperinflammation in Adult Patients with Sepsis or a Septic Condition - GlobeNewsWire
- 5 days ago - SeaStar Medical Announces Exercise of Warrants for Approximately $3.3 Million Gross Proceeds - GlobeNewsWire
- 8 days ago - SeaStar Medical Announces Late-Breaking Presentation at ASN Kidney Week 2026 - GlobeNewsWire
- 9 days ago - SeaStar Medical announces codes available for use of SCD therapy for AKI - TheFly
- 9 days ago - New ICD-10-PCS Codes are Now Available for the Use of SeaStar Medical's SCD Therapy for Acute Kidney Injury (AKI) - GlobeNewsWire
- 11 days ago - SeaStar Medical Announces Chief Medical Officer, Kevin Chung, M.D., to Present at the Pediatric Paracorporeal and Extracorporeal Therapy Symposium (PPETS) 2026 - GlobeNewsWire
- 16 days ago - SeaStar Medical Congratulates H. David Humes, M.D. - GlobeNewsWire